These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 16352895)

  • 1. p16 Gene methylation in colorectal tumors: correlation with clinicopathological features and prognostic value.
    Sanz-Casla MT; Maestro ML; Vidaurreta M; Maestro C; Arroyo M; Cerdán J
    Dig Dis; 2005; 23(2):151-5. PubMed ID: 16352895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of methylated p15 and p16 genes on clinicopathological features in colorectal cancer.
    Ishiguro A; Takahata T; Saito M; Yoshiya G; Tamura Y; Sasaki M; Munakata A
    J Gastroenterol Hepatol; 2006 Aug; 21(8):1334-9. PubMed ID: 16872319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypermethylation of the CDKN2A gene in colorectal cancer is associated with shorter survival.
    Maeda K; Kawakami K; Ishida Y; Ishiguro K; Omura K; Watanabe G
    Oncol Rep; 2003; 10(4):935-8. PubMed ID: 12792748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivation of p16INK4a by CpG hypermethylation is not a frequent event in colorectal cancer.
    Norrie MW; Hawkins NJ; Todd AV; Meagher AP; O'Connor TW; Ward RL
    J Surg Oncol; 2003 Nov; 84(3):143-50. PubMed ID: 14598358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant methylation of the p16 gene is frequently detected in advanced colorectal cancer.
    Goto T; Mizukami H; Shirahata A; Sakata M; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y; Hibi K
    Anticancer Res; 2009 Jan; 29(1):275-7. PubMed ID: 19331161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential impact of p16 inactivation by promoter methylation in non-small cell lung and colorectal cancer: clinical implications.
    González-Quevedo R; García-Aranda C; Morán A; De Juan C; Sánchez-Pernaute A; Torres A; Díaz-Rubio E; Balibrea JL; Benito M; Iniesta P
    Int J Oncol; 2004 Feb; 24(2):349-55. PubMed ID: 14719111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between expression and methylation status of p16INK4a and the proliferative activity of different areas' tumour cells in human colorectal cancer.
    Jie G; Zhixiang S; Lei S; Hesheng L; Xiaojun T
    Int J Clin Pract; 2007 Sep; 61(9):1523-9. PubMed ID: 17537196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylation of the MGMT and p16 genes in sporadic colorectal carcinoma and corresponding normal colonic mucosa.
    Krakowczyk L; Strzelczyk JK; Adamek B; Zalewska-Ziob M; Arendt J; Półtorak S; Maciejewski B; Wiczkowski A
    Med Sci Monit; 2008 Oct; 14(10):BR219-25. PubMed ID: 18830187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse prognostic effect of methylation in colorectal cancer is reversed by microsatellite instability.
    Ward RL; Cheong K; Ku SL; Meagher A; O'Connor T; Hawkins NJ
    J Clin Oncol; 2003 Oct; 21(20):3729-36. PubMed ID: 14551292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P16 methylation in serum as a potential marker for the malignancy of colorectal carcinoma.
    Nakayama G; Hibi K; Kodera Y; Koike M; Fujiwara M; Nakao A
    Anticancer Res; 2007; 27(5A):3367-70. PubMed ID: 17970082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypermethylation of the MYOD1 gene is a novel prognostic factor in patients with colorectal cancer.
    Hiranuma C; Kawakami K; Oyama K; Ota N; Omura K; Watanabe G
    Int J Mol Med; 2004 Mar; 13(3):413-7. PubMed ID: 14767572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylation of tumor suppressor gene p16 and prognosis of epithelial ovarian cancer.
    Katsaros D; Cho W; Singal R; Fracchioli S; Rigault De La Longrais IA; Arisio R; Massobrio M; Smith M; Zheng W; Glass J; Yu H
    Gynecol Oncol; 2004 Sep; 94(3):685-92. PubMed ID: 15350359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The methylation status and protein expression of CDH1, p16(INK4A), and fragile histidine triad in nonsmall cell lung carcinoma: epigenetic silencing, clinical features, and prognostic significance.
    Nakata S; Sugio K; Uramoto H; Oyama T; Hanagiri T; Morita M; Yasumoto K
    Cancer; 2006 May; 106(10):2190-9. PubMed ID: 16598757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promoter hypermethylation of tumor-related genes in peritoneal lavage and the prognosis of patients with colorectal cancer.
    Kamiyama H; Noda H; Takata O; Suzuki K; Kawamura Y; Konishi F
    J Surg Oncol; 2009 Jul; 100(1):69-74. PubMed ID: 19384904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylation of serum DNA is an independent prognostic marker in colorectal cancer.
    Wallner M; Herbst A; Behrens A; Crispin A; Stieber P; Göke B; Lamerz R; Kolligs FT
    Clin Cancer Res; 2006 Dec; 12(24):7347-52. PubMed ID: 17189406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of inactivation of the p16INK4a gene in leiomyosarcoma of soft tissue: decreased p16 expression correlates with promoter methylation and poor prognosis.
    Kawaguchi K; Oda Y; Saito T; Yamamoto H; Tamiya S; Takahira T; Miyajima K; Iwamoto Y; Tsuneyoshi M
    J Pathol; 2003 Nov; 201(3):487-95. PubMed ID: 14595762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant methylation of p16INK4a in anatomic and gender-specific subtypes of sporadic colorectal cancer.
    Wiencke JK; Zheng S; Lafuente A; Lafuente MJ; Grudzen C; Wrensch MR; Miike R; Ballesta A; Trias M
    Cancer Epidemiol Biomarkers Prev; 1999 Jun; 8(6):501-6. PubMed ID: 10385139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p16 gene methylation in colorectal cancer patients with long-term follow-up.
    Veganzones-de-Castro S; Rafael-Fernández S; Vidaurreta-Lázaro M; de-la-Orden V; Mediero-Valeros B; Fernández C; Maestro-de las Casas ML
    Rev Esp Enferm Dig; 2012 Mar; 104(3):111-7. PubMed ID: 22449151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylation of p16 CpG island associated with malignant progression of oral epithelial dysplasia: a prospective cohort study.
    Cao J; Zhou J; Gao Y; Gu L; Meng H; Liu H; Deng D
    Clin Cancer Res; 2009 Aug; 15(16):5178-83. PubMed ID: 19671846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p16(INK4a) promoter methylation and 9p21 allelic loss in colorectal carcinomas: relation with immunohistochemical p16(INK4a) expression and with tumor budding.
    Prall F; Ostwald C; Weirich V; Nizze H
    Hum Pathol; 2006 May; 37(5):578-85. PubMed ID: 16647956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.